Trey Lavender

• Spearheaded strategic growth by integrating 18 hospital satellite locations for infectious disease testing, leveraging reputable hospital accounts to build credibility and expand downstream partnerships with 50+ medical practices.
• Ensured strict adherence to HIPAA, Stark, Anti-Kickback, and EKRA laws, demonstrating strong compliance leadership in a complex regulatory environment.
• Navigated CMS, Medicaid, and commercial insurance challenges, developing solutions that safeguarded compliance while supporting patient access to care.
• Strengthened physician relationships by delivering education on testing protocols and EMR integrations, fostering trust and long-term collaboration.
• Negotiated vendor and customer agreements to reduce expenses, mitigate risk, and protect company assets through sound contractual practices.

• Embedded Kerendia into Alabama’s largest nephrology group.

• Selected to National Advisory Board (KFAB) for compliance and rollout strategy.

• Consistently surpassed performance expectations while maintaining strict regulatory adherence.

• Achieved 101% territory growth through data-driven compliance strategies.

• Navigated Medicare/Medicaid reimbursement frameworks to expand patient access.

• Partnered with UAB to support intravenous biologic programs under federal guidelines.

• Expanded market share for biologics (Toujeo, Soliqua, Lantus), consistently exceeding quotas.

• Earned 2018 Sales Award for being the only Gulf Coast Region territory exceeding quota in consecutive quarters.

• Implemented data-driven strategies to optimize targeting and lead generation.

• Collaborated on compliant product launches with cross-functional teams.

• Founded a medical distributorship focusing on immunology, genetics, and chronic care management solutions.

• Managed daily operations, finances, compliance, and contract negotiations with suppliers.

• Established operational processes ensuring full compliance with evolving healthcare regulations.

• Launched biologic Toujeo, consistently ranking in the top 5 regionally from launch.
• Executed targeted sales strategies in the diabetes market, while adhering to all regulatory and compliance polices
• Selected as 1 of 20 candidates to interview for Home office preceptorship, was 1 of 2 selected for 6 month preceptorship in Bridgewater,NJ with focus on Managed Markets and Leadership Development

• Developed and executed market growth strategy for Asacol, achieving #1 market share nationally.

• Exceeded performance targets and maintained compliance with corporate policies.

• Marketed facial reconstruction and neuro plating surgical solutions to physicians and healthcare executives.

• Maintained accurate contracts, records, and compliance documentation.

• Achieved district #1 rankings in competitive hypertension, diabetes, and cholesterol markets.

• Developed compliant territory business plans aligned with corporate sales objectives.

• Educated physicians and pharmacists on safe and effective drug use within FDA guidelines.